E-Cigarette Regulation: The Past, Present, and Future of the FDA’s Gatekeeping Role

You are here

Date: 
Tuesday, April 20, 2021

According to federal law, all e-cigarettes must go through a process called “premarket review” to be commercially marketed in the U.S. So far, no e-cigarette has received marketing authorization from the FDA. Yet, after September 9, 2021, the only e-cigarette products that should remain on store shelves are those that have received affirmative marketing authorization. This webinar will provide background on the premarket review process, update viewers on the progress of the FDA’s ongoing review of millions of tobacco products, and discuss what might happen after the September 9, 2021, deadline.

Resources:
Zettler, Patricia J. and Hemmerich, Natalie and Berman, Micah, Closing the Regulatory Gap for Synthetic Nicotine (October 1, 2017). Boston College Law Review, vol. 59, 2018, Georgia State University College of Law, Legal Studies Research Paper No. 2018-03, Ohio State Public Law Working Paper No. 425, Available at SSRN: https://ssrn.com/abstract=3045317
Closing the Regulatory Gap for Synthetic Nicotine Products Poster
Webinar Slides

Presenters:
Kyra Hill, Public Health Law Center
Mike Merissa, Public Health Law Center

Moderator:
Desmond Jenson, Public Health Law Center